Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
GW Pharmaceuticals Plc
GWPHV
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:GWPHV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(140)
•••
INVESTigator1
X
View Profile
View Bullboard History
Post by
INVESTigator1
on May 13, 2021 2:23pm
Planet 13 and AMA/1933 Las Vegas
Planet 13 Las Vegas Regarding 1933 Industries (TGIFF)/AMA Quality and Products: "They've combined large-scale cultivation and extraction to perfect the experience of every strain. From Black
...more
(140)
•••
INVESTigator1
X
View Profile
View Bullboard History
Post by
INVESTigator1
on May 11, 2021 6:53pm
Planet 13 and AMA/1933 Las Vegas
Good Products: https://www.instagram.com/p/COvammkL6Yf/
(140)
•••
INVESTigator1
X
View Profile
View Bullboard History
Post by
INVESTigator1
on May 07, 2021 1:05pm
TGIFF 1933 Industries - Nevada dispensaries everywhere...
Deliveries of flower, concentrates, badder, diamonds, exotics, crumble, pre-rolls, disposable vapes, CBDs & more... Can't keep track anymore this year: Penetration is getting real!!! And
...more
(140)
•••
INVESTigator1
X
View Profile
View Bullboard History
Post by
INVESTigator1
on May 05, 2021 11:38am
1933 Industries Preferred Supplier Las Vegas & Nevada
If anyone is looking for a cannabis stock that will easily quadruple and more this year – TGIFF (US) TGIF (CN) is the ticker with the AMA and Canna Hemp (CBD) high quality products, It has huge
...more
(81)
•••
jackthebear1
X
View Profile
View Bullboard History
Post by
jackthebear1
on Apr 21, 2021 8:43am
Tetra interviews
The tbp board has recently added 2 interviews and the comparison to GW is mentioned and the upside in the shareprice potential is staggering. Anybody over hear follow it.
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jan 11, 2021 8:25am
GW Pharma Earnings
As InMed Pharma investor, I'm watching both closely since once GW ramps up clinical trials with rare cannabinoids, they are likely to use InMed manufacturing technology. https://www
...more
(14)
•••
SmallCapIntel
X
View Profile
View Bullboard History
Post by
SmallCapIntel
on Jan 06, 2021 8:36am
HempFusion Going Public with $30M Cash USD
Wild numbers by a companies in the CBD space. Goes public today TSX:CBD.U https://twitter.com/SagacityCm/status/1346803419105943553
(28)
•••
cannabisc
X
View Profile
View Bullboard History
Post by
cannabisc
on Nov 07, 2020 6:33pm
CEO buys over 500k shares
The CEO of the only cannabis companies to report cash positive EBITDA buys over 500k shares insider trading canada GTEC Holdings - TSXV-GTEC https://www.gtec.co/wp-content
...more
(0)
•••
Nonyah
X
View Profile
View Bullboard History
Post by
Nonyah
on Jul 13, 2020 6:03pm
TCI Insider Trading Report
https://www.thecannabisinvestor.ca/tci-insider-trading-report-top-cannabis-stocks-with-recent-insider-trading-activity/
(0)
•••
Nonyah
X
View Profile
View Bullboard History
Post by
Nonyah
on May 11, 2020 10:02pm
$5 B Market Valuation for Psychedelics May be Too Low
A $5 Billion Market Valuation for Psychedelics May be Too Low Psychedelics Have Gone Mainstream, All Thanks to a Wide Range of Research That Points to Success in Treating a Range of Mental and Other
...more
(25)
•••
supergarvis
X
View Profile
View Bullboard History
Post by
supergarvis
on Mar 13, 2020 9:16am
NEWS OUT 🔈
https://thecannabisstock.com/2020/03/13/gw-pharmaceuticals-submits-type-ii-variation-application-to-the-european-medicines-agency-ema-to-expand-the-use-of-epidyolex/
(6)
•••
indaknownewfie
X
View Profile
View Bullboard History
Post by
indaknownewfie
on Mar 09, 2020 10:16pm
Any buyout or partnership news?
Wondering if you are looking at buying out a combined Kalytera/Stero/Talent which would make you dominant in CBD worldwide. #epidiolex+++++
(25)
•••
supergarvis
X
View Profile
View Bullboard History
Post by
supergarvis
on Mar 02, 2020 12:31pm
Breaking news out 🚨
https://thecannabisstock.com/2020/03/02/jama-neurology-publishes-results-from-positive-phase-3-trial-of-epidiolex-cannabidiol-oral-solution-in-children-with-seizures-associated-with-dravet-syndrome/
(6)
•••
indaknownewfie
X
View Profile
View Bullboard History
Comment by
indaknownewfie
on Feb 24, 2020 9:09pm
RE:RE:$GWPH: Why Investors Should be Bullish About GWPH
Could they be partnering with another company like Kalytera therapeutics v.kly who received an exclusive European patent this past Friday through Mor for CBD used to Prevent and Treat acute and
...more
(0)
•••
Nonyah
X
View Profile
View Bullboard History
Post by
Nonyah
on Feb 11, 2020 4:37pm
Cannabis Countdown: Top 10 Marijuana Industry News Stories
Cannabis Countdown: Top 10 Marijuana Industry News Stories of the Week Click here to catch up on the news
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income